(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

The last few months have been tough for UK stocks and their troubles aren't over yet, but Harvey Jones isn't worried. He sees ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

Discover more on Bavarian Nordic's vaccine sales decline, diversification strategy, and strong Travel Health segment, ...

Married couples and civil partners can inherit from each other free of inheritance tax. But siblings who live together in old ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical ...

The banks have been quietly celebrating. The oil and gas giants are preparing fresh investment plans. The tech giants have ...

I’ve just bought two US growth companies on my best stocks to buy now list, and I think they’re still terrific long-term ...

Health stocks tumbled as vaccine sceptic RFK Jr. was named by President-elect Trump to head the Department of Health and ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

Back in Europe, shares in pharmaceutical giant GSK tumbled to a two-year low after Trump's appointment of vaccine sceptic ...

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.